93 related articles for article (PubMed ID: 15110189)
1. Gene Expression of Molecules Regulating Apoptotic Pathways in Glioblastoma Multiforme Treated with Umbilical Cord Stem Cell Conditioned Medium.
Hardiany NS; Yo EC; Ngadiono E; Wanandi SI
Malays J Med Sci; 2019 Nov; 26(6):35-45. PubMed ID: 31908585
[TBL] [Abstract][Full Text] [Related]
2. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
[TBL] [Abstract][Full Text] [Related]
3. Targeted Nanotechnology in Glioblastoma Multiforme.
Glaser T; Han I; Wu L; Zeng X
Front Pharmacol; 2017; 8():166. PubMed ID: 28408882
[TBL] [Abstract][Full Text] [Related]
4. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
Gao S; Li J; Jiang C; Hong B; Hao B
Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
[TBL] [Abstract][Full Text] [Related]
5. Shogaol overcomes TRAIL resistance in colon cancer cells via inhibiting of survivin.
Hwang JS; Lee HC; Oh SC; Lee DH; Kwon KH
Tumour Biol; 2015 Nov; 36(11):8819-29. PubMed ID: 26063410
[TBL] [Abstract][Full Text] [Related]
6. Gingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cells.
Lee DH; Kim DW; Jung CH; Lee YJ; Park D
Toxicol Appl Pharmacol; 2014 Sep; 279(3):253-265. PubMed ID: 25034532
[TBL] [Abstract][Full Text] [Related]
7. A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis.
Kranz D; Boutros M
EMBO J; 2014 Feb; 33(3):181-97. PubMed ID: 24442637
[TBL] [Abstract][Full Text] [Related]
8. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.
Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E
PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic nanomedicine for brain cancer.
Tzeng SY; Green JJ
Ther Deliv; 2013 Jun; 4(6):687-704. PubMed ID: 23738667
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.
Peterson CW; Younan P; Jerome KR; Kiem HP
Gene Ther; 2013 Jul; 20(7):695-702. PubMed ID: 23364313
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.
Kim IY; Kang YJ; Yoon MJ; Kim EH; Kim SU; Kwon TK; Kim IA; Choi KS
Neuro Oncol; 2011 Mar; 13(3):267-79. PubMed ID: 21292685
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
Ashley DM; Riffkin CD; Lovric MM; Mikeska T; Dobrovic A; Maxwell JA; Friedman HS; Drummond KJ; Kaye AH; Gan HK; Johns TG; Hawkins CJ
Br J Cancer; 2008 Jul; 99(2):294-304. PubMed ID: 18594532
[TBL] [Abstract][Full Text] [Related]
13. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro.
Wang WX; Ji YH
J Neurooncol; 2005 May; 73(1):1-7. PubMed ID: 15933810
[TBL] [Abstract][Full Text] [Related]
14. TRAIL and malignant glioma.
Hawkins CJ
Vitam Horm; 2004; 67():427-52. PubMed ID: 15110189
[TBL] [Abstract][Full Text] [Related]
15. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
[TBL] [Abstract][Full Text] [Related]
16. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
Fulda S; Wick W; Weller M; Debatin KM
Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
Mori T; Doi R; Toyoda E; Koizumi M; Ito D; Kami K; Kida A; Masui T; Kawaguchi Y; Fujimoto K
Surgery; 2005 Jul; 138(1):71-7. PubMed ID: 16003319
[TBL] [Abstract][Full Text] [Related]
18. TRAIL and apoptosis induction by TNF-family death receptors.
Wang S; El-Deiry WS
Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624
[TBL] [Abstract][Full Text] [Related]
19. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.
Van Geelen CM; de Vries EG; de Jong S
Drug Resist Updat; 2004 Dec; 7(6):345-58. PubMed ID: 15790545
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
